FGAIM: Identifying Drug-Target Activation and Inhibition Mechanisms via Inductive Graph Neural Networks Based on Fine-Grained Interaction Strategies.

Yi Tang, Yongxian Fan, Guicong Sun, Mengxin Zheng
{"title":"FGAIM: Identifying Drug-Target Activation and Inhibition Mechanisms via Inductive Graph Neural Networks Based on Fine-Grained Interaction Strategies.","authors":"Yi Tang, Yongxian Fan, Guicong Sun, Mengxin Zheng","doi":"10.1109/TCBBIO.2026.3695928","DOIUrl":null,"url":null,"abstract":"<p><p>Distinguishing the activation and inhibition mechanisms between drugs and targets can reveal the potential regulatory pathways of target functions, which is crucial in drug discovery and development. Although numerous deep learning-based computational methods have been proposed, most of them extract drug and target features independently while neglecting interactions between drug molecules and protein residues. In addition, existing methods approach drugs in a relatively simple way and predominantly rely on protein sequence information. Deep learning, particularly graph neural networks (GNNs), has demonstrated unique advantages in processing data with complex graph-structured relationships. Motivated by these limitations, this study proposes a novel computational method named FGAIM, which designed to effectively identify activation and inhibition mechanisms between drugs and targets. First, a multi-scale GNN module in FGAIM is employed to learn expressive drug molecular embeddings. At the same time, protein representations are constructed by integrating pre-trained language model (PLM) embeddings and structural information derived from 3D conformations. Subsequently, FGAIM leverages a GraphSAGE module to extract features from both the primary drug graph and the fine-grained drug-protein interaction graph. Finally, the resulting drug and target embeddings are fused and fed into a Multilayer Perceptron (MLP) for classification prediction. Comparative experiments on two public datasets demonstrate that FGAIM significantly outperforms existing computational approaches and exhibits strong generalization capabilities. Further case studies reveal the advantages of FGAIM in mining previously unrecognized activation/inhibition relationships. Building upon the fine-grained interactions, we further explored the model's interpretability at the molecular structural level through analysis of attention weights. Additionally, visualization analyses confirm that FGAIM effectively captures underlying structural patterns in the data and identifies discriminative features across different categories.</p>","PeriodicalId":520987,"journal":{"name":"IEEE transactions on computational biology and bioinformatics","volume":"PP ","pages":"1671-1683"},"PeriodicalIF":0.0000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE transactions on computational biology and bioinformatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/TCBBIO.2026.3695928","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Distinguishing the activation and inhibition mechanisms between drugs and targets can reveal the potential regulatory pathways of target functions, which is crucial in drug discovery and development. Although numerous deep learning-based computational methods have been proposed, most of them extract drug and target features independently while neglecting interactions between drug molecules and protein residues. In addition, existing methods approach drugs in a relatively simple way and predominantly rely on protein sequence information. Deep learning, particularly graph neural networks (GNNs), has demonstrated unique advantages in processing data with complex graph-structured relationships. Motivated by these limitations, this study proposes a novel computational method named FGAIM, which designed to effectively identify activation and inhibition mechanisms between drugs and targets. First, a multi-scale GNN module in FGAIM is employed to learn expressive drug molecular embeddings. At the same time, protein representations are constructed by integrating pre-trained language model (PLM) embeddings and structural information derived from 3D conformations. Subsequently, FGAIM leverages a GraphSAGE module to extract features from both the primary drug graph and the fine-grained drug-protein interaction graph. Finally, the resulting drug and target embeddings are fused and fed into a Multilayer Perceptron (MLP) for classification prediction. Comparative experiments on two public datasets demonstrate that FGAIM significantly outperforms existing computational approaches and exhibits strong generalization capabilities. Further case studies reveal the advantages of FGAIM in mining previously unrecognized activation/inhibition relationships. Building upon the fine-grained interactions, we further explored the model's interpretability at the molecular structural level through analysis of attention weights. Additionally, visualization analyses confirm that FGAIM effectively captures underlying structural patterns in the data and identifies discriminative features across different categories.

FGAIM:基于细粒度相互作用策略的归纳图神经网络识别药物靶标激活和抑制机制。
区分药物与靶点之间的激活和抑制机制,可以揭示靶点功能的潜在调控途径,这对药物的发现和开发至关重要。虽然已经提出了许多基于深度学习的计算方法,但大多数方法都是独立提取药物和靶标特征,而忽略了药物分子与蛋白质残基之间的相互作用。此外,现有方法接近药物的方法相对简单,主要依赖于蛋白质序列信息。深度学习,特别是图神经网络(gnn),在处理具有复杂图结构关系的数据方面显示出独特的优势。基于这些局限性,本研究提出了一种名为FGAIM的新型计算计算方法,旨在有效识别药物与靶点之间的激活和抑制机制。首先,利用FGAIM中的多尺度GNN模块学习表达性药物分子嵌入。同时,通过整合预训练语言模型(PLM)嵌入和来自三维构象的结构信息来构建蛋白质表示。随后,FGAIM利用GraphSAGE模块从初级药物图和细粒度药物-蛋白质相互作用图中提取特征。最后,将得到的药物和目标嵌入融合并馈送到多层感知器(MLP)中进行分类预测。在两个公共数据集上的对比实验表明,FGAIM显著优于现有的计算方法,并表现出强大的泛化能力。进一步的案例研究揭示了FGAIM在发现以前未被识别的激活/抑制关系方面的优势。在细粒度相互作用的基础上,我们通过分析注意力权重进一步探索了模型在分子结构水平上的可解释性。此外,可视化分析证实,FGAIM有效地捕获了数据中的潜在结构模式,并识别出不同类别的区别特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书